KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Net Income towards Common Stockholders (2016 - 2026)

Medtronic's Net Income towards Common Stockholders history spans 13 years, with the latest figure at $1.2 billion for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders fell 11.74% year-over-year to $1.2 billion; the TTM value through Jan 2026 reached $4.6 billion, up 8.23%, while the annual FY2025 figure was $4.7 billion, 26.67% up from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 was $1.2 billion at Medtronic, down from $1.4 billion in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $1.5 billion in Q2 2022 and bottomed at $436.0 million in Q4 2022.
  • The 5-year median for Net Income towards Common Stockholders is $1.2 billion (2026), against an average of $1.1 billion.
  • The largest annual shift saw Net Income towards Common Stockholders crashed 66.89% in 2022 before it soared 108.94% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $436.0 million in 2022, then skyrocketed by 108.94% to $911.0 million in 2023, then soared by 40.29% to $1.3 billion in 2024, then grew by 8.06% to $1.4 billion in 2025, then fell by 16.73% to $1.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Net Income towards Common Stockholders are $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.0 billion (Q3 2025).